Latest News & Updates
Breaking News
7 minutes ago
Simantini Singh Deo
Other trending news you may like to read
Fortress Biotech & Cyprium Therapeutics Secure U.S. FDA Approval For ZYCUBO®, The First Approved Menkes Disease Therapy
The FDA approves ZYCUBO as the first-ever U.S. therapy for pediatric Menkes disease, a rare and life-threatening disorder.
Simantini Singh Deo
Aligos Therapeutics Appoints James Hassard As Executive VP And Chief Commercial Officer To Strengthen Senior Leadership
Aligos Therapeutics appoints James Hassard as EVP and CCO to lead global commercial strategy as key liver disease programs advance.
Simantini Singh Deo
AbbVie And Trump Administration Reach Deal To Expand Drug Access And Invest $100 Billion In U.S. Innovation
AbbVie commits to lower Medicaid pricing and $100B in U.S. R&D and manufacturing to improve drug access and affordability.
Vaibhavi M.
20260113181608.jpg)
Amneal Reveals New Brand Identity To Reflect Its Evolution Into A Global Biopharma Leader; Reinforce Its Mission Of Expanding Access To Essential Medicines
Amneal introduces a refreshed brand and visual identity highlighting its growth beyond generics into complex and specialty medicines.
Vaibhavi M.
